MCLEAN, Va., March 4, 2021 /PRNewswire/ — The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs today referred certain product performance and earnings claims made by RBC Life Sciences to the Federal Trade Commission (FTC) for possible enforcement action after RBC Life Sciences failed to provide substantiation for the claims.
At issue in DSSRC’s inquiry are earnings and health-related product performance claims disseminated by salesforce members implying that RBC Life Sciences products can prevent and/or treat several serious health-related conditions, including COVID-19. In addition, RBC Life Sciences’ salesforce members have made egregious representations in social media posts about income that can be earned as a member of the RBC Life Sciences salesforce. In addition, on its website, RBC Life Sciences falsely represented that it is an accredited business with the Better Business Bureau and a member of the Direct Selling Association.
RBC Life Sciences, a direct-selling company offering nutritional and wellness products, has approximately 10,000 independent distributors in the U.S. and Canada. The following representative claims were brought to RBC Life Sciences attention by the DSSRC as part of its ongoing independent monitoring of the direct selling marketplace.
See original story at prnewswire.com